Nexalin Technology (NXL) Cash from Operations (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Cash from Operations of 1712988.0 for Q1 2026, down 20.11% year-over-year from 2144112.43 in Q1 2025, and down 49.21% quarter-over-quarter from 1148022.0 in Q4 2025.
Nexalin Technology (NXL) Cash from Operations (2021 - 2026) Analysis & Trends
Nexalin Technology's Cash from Operations history runs 6 years deep, the most recent figure standing at 1712988.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 20.11% year-over-year to 1712988.0; the TTM figure through Mar 2026 stood at 5244432.0 (down 13.83% YoY), while the FY2025 annual figure was 4957658.0, down 25.69% from the prior year.
- Cash from Operations for Q1 2026 stood at 1712988.0, down from 1148022.0 in the prior quarter.
- The five-year high for Cash from Operations was 162272.0 in Q2 2022, with the low at 1712988.0 in Q1 2026.
- The 5-year median for Cash from Operations is 943699.0 (2022), against an average of 980359.94.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations plunged 546.75% in 2023, then soared 41.94% in 2024.
- Nexalin Technology's Cash from Operations stood at 906457.0 in 2022, then fell by 10.76% to 1004030.0 in 2023, then decreased by 12.99% to 1134476.0 in 2024, then dropped by 1.19% to 1148022.0 in 2025, then slumped by 49.21% to 1712988.0 in 2026.
- Business Quant data shows NXL's Cash from Operations at 1712988.0 in Q1 2026, 1148022.0 in Q4 2025, and 1466257.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 | -1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.80 Mn |
| Jun 30, 2026 | -1.80 Mn |
| Mar 31, 2026 | -1.71 Mn |
| Mar 31, 2026 | -1.71 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Jun 30, 2025 | -917,165.00 |
| Jun 30, 2025 | -917,165.00 |
| Mar 31, 2025 | -1.43 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | -800,210.00 |
| Sep 30, 2024 | -800,210.00 |
| Jun 30, 2024 | -1.25 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -763,289.00 |
| Mar 31, 2024 | -763,289.00 |